© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
Jennifer B. Green, MD, and Dennis Bruemmer, MD, PhD, have a conversation on the rise of Type 2 diabetes worldwide, and the available and upcoming treatment options.
November 12th 2021
Jennifer B. Green, MD, and Dennis Bruemmer, MD, PhD, discuss the increasing prevalence of type 2 diabetes around the world, and the populations facing higher risk.
An expert cardiologist and endocrinologist explain the factors considered when creating a treatment plan for type 2 diabetes.
November 19th 2021
Drs Jennifer Green and Dennis Bruemmer share advice for treating complicated cases of type 2 diabetes with comorbidities.
Key opinion leaders review the recent ADA standards of care for type 2 diabetes.
November 26th 2021
Dennis Bruemmer, MD, PhD, and Jennifer B. Green, MD, have a conversation about the use of SGLT2 inhibitors and GLP1 receptor agonists in treating type 2 diabetes.
Thought leaders discuss recent advances in treatments for patients with type 2 diabetes with chronic kidney disease.